Ocular Therapeutix
OCUL
OCUL
70 hedge funds and large institutions have $309M invested in Ocular Therapeutix in 2015 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 36 increasing their positions, 7 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
19% less capital invested
Capital invested by funds: $380M → $309M (-$71.1M)
20% less call options, than puts
Call options by funds: $650K | Put options by funds: $814K
Holders
70
Holding in Top 10
4
Calls
$650K
Puts
$814K
Top Buyers
| 1 | +$31.1M | |
| 2 | +$7.34M | |
| 3 | +$5.2M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$5.04M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.43M |
Top Sellers
| 1 | -$6.22M | |
| 2 | -$3.37M | |
| 3 | -$2.07M | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$1.42M |
| 5 |
D.E. Shaw & Co
New York
|
-$987K |